chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Leg was cramping; Felt a little warm; Didn't feel well; Heart was racing; Had trouble trying to catch a breath; Immediately go to the bathroom and had diarrhoea; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel well), PALPITATIONS (Heart was racing), DYSPNOEA (Had trouble trying to catch a breath), DIARRHOEA (Immediately go to the bathroom and had diarrhoea) and MUSCLE SPASMS (Leg was cramping) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jun-2021, the patient experienced MALAISE (Didn't feel well), PALPITATIONS (Heart was racing), DYSPNOEA (Had trouble trying to catch a breath) and DIARRHOEA (Immediately go to the bathroom and had diarrhoea). On 23-Jun-2021, the patient experienced MUSCLE SPASMS (Leg was cramping) and FEELING HOT (Felt a little warm). On 22-Jun-2021, MALAISE (Didn't feel well), PALPITATIONS (Heart was racing), DYSPNOEA (Had trouble trying to catch a breath) and DIARRHOEA (Immediately go to the bathroom and had diarrhoea) outcome was unknown. At the time of the report, MUSCLE SPASMS (Leg was cramping) and FEELING HOT (Felt a little warm) outcome was unknown.            No concomitant medications were provided. No treatment details were provided.   Reporter did not allow further contact
fever; insomia; Joint pain; muscle aches; flu like symptoms; Chills; nausea; he was aching; losing appetite; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), INSOMNIA (insomia), ARTHRALGIA (Joint pain), MYALGIA (muscle aches) and INFLUENZA LIKE ILLNESS (flu like symptoms) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PYREXIA (fever), INSOMNIA (insomia), ARTHRALGIA (Joint pain), MYALGIA (muscle aches), INFLUENZA LIKE ILLNESS (flu like symptoms), CHILLS (Chills), NAUSEA (nausea), PAIN (he was aching) and DECREASED APPETITE (losing appetite). On 07-Mar-2021, PYREXIA (fever), INSOMNIA (insomia), ARTHRALGIA (Joint pain), MYALGIA (muscle aches), INFLUENZA LIKE ILLNESS (flu like symptoms), CHILLS (Chills), NAUSEA (nausea), PAIN (he was aching) and DECREASED APPETITE (losing appetite) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported.
This spontaneous report was received from a physician referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 11-FEB-2019, the patient was vaccinated with PROQUAD in the arm lot number reported as R014355, with expiration date on 21-MAY-2021 (dosage scheduleand route were not reported), indicated for prophylaxis, reconstituted with sterile diluent. During the vaccine administration, the patient moved the arm causing the needle to come out of the arm before the complete dose was administered. Lot number R014355 was an invalid lot number for PROQUAD.
Patient is a 27 y.o. male patient of DO with history of asthma, anxiety who presented to Hospital ED with COVID-19.   Acute Hypoxic Respiratory Failure COVID-19 Severe persistent asthma Positive COVID exposure 9/11 with development of symptoms (cough, nasal congestion, SOB) starting 9/13 with progressive worsening.  Patient has not had COVID before.  Received COVID vaccine x2 plus 1 booster.  Last hospitalization for asthma April 2022 2/2 flu and required intubation.  At HED, required 4L NC due to frequent desats <90% prompting transfer.  Received duoneb x1, dex 10mg in ED. CXR unremarkable.  Labs with leukocytosis 12.25-- >15.53-- > 12.67 Continue home inhalers (ICS/LABA, LAMA), montelukast Scheduled/prn albuterol nebs Continue dexamethasone 6mg daily-- > finish off 10 day total course on dischagre Received 2 doses remdesivir before being able to maintain on RA Continue supplemental O2 to maintain O2 sats >92% Pulmonary hygiene   Tachycardia-resolved  Tachy to 1-teens upon transfer to H Suspect in setting of acute illness, consistent albuterol use over past 72 hours.  No pleuritic chest pain.   GAD PTSD Continue home Prozac
About 15 minutes after receiving the vaccination c/o feeling lightheaded and like she needed to lay down. Rested for about 30 minutes and felt fine. Ambulated without issue and went home.
Diarrhea - 1-18-14 last -> 1-18-14. Nausea - 1-17-14 -> 1-19-14. Headache - 1-17-14 -> 1-19-14. Stomach pain 1-19-14. Arm was red, swollen, and warm, sore - 1-18-14 -> 1-19-14.
Intussusception on 9-24-09.  Required a bowel resection. 10/21/09 Hospital discharge summary received service dates 9/16/09 to 9/21/09. Assessment: Status post exploratory laparotomy for intussusception. Hemicolectomy secondary to intussusception. Patient presented with a one day history of bloody stools and repeated episodes of emesis. Diagnosed with intussusception.  11/3/2009 ICD-9 codes 560.0, 285.9
Pt presented to HD in no acute distress 11/13. Shots given 11/10/08. Mother states child was taken to ER 11/12. Received steroid shot for allergic reaction, erythematous area 9-10 cm in child's  Dr. prescribed amoxcillin.
Bursitis like pain left arm, hurts to move, redness, swelling, was feverish but that is  better.
Was patient pregnant while using the product - Yes; This prospective pregnancy case was reported by a consumer via patient support programs and described the occurrence of vaccine exposure during pregnancy in a 39-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number 953Y2, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 11th April 2022, the patient received Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. The patient's last menstrual period was on an unknown date and estimated date of delivery was 5th April 2022. The patient received Fluarix Quadrivalent 2021-2022 season at an unknown time during the pregnancy. On an unknown date, unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced vaccine exposure during pregnancy. On an unknown date, the outcome of the vaccine exposure during pregnancy was unknown. The pregnancy was ongoing.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 08-NOV-2022 Reporter's comment: This case was reported by a consumer via (McKesson) patient support programs.  The reporter stated that patient received vaccine when the patient was pregnant. The reporter also confirmed that vaccine was not expired.
Complete vision loss in right eye for about 1 minute.  Diziness.  no residual effect.  possibility of clot?
pt recv vax 10MAY97 & 20MAY97 pt exp vaccine related rash;the reporter felt that rash was related to therapy w/varicella vax;
had leg nervousness after taking the shot.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jun-2021 and was forwarded to Moderna on 18-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (had leg nervousness after taking the shot.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (had leg nervousness after taking the shot.). At the time of the report, LIMB DISCOMFORT (had leg nervousness after taking the shot.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The Concomitant medication information were not provided.  The Treatment medication information  was not provided.    Reporter did not allow further contact
A lot of vaccine squirted from her arm during administration; Did not receive the entire dosage; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCHARGE (A lot of vaccine squirted from her arm during administration) and UNDERDOSE (Did not receive the entire dosage) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE DISCHARGE (A lot of vaccine squirted from her arm during administration) and UNDERDOSE (Did not receive the entire dosage). On 17-Mar-2021, VACCINATION SITE DISCHARGE (A lot of vaccine squirted from her arm during administration) and UNDERDOSE (Did not receive the entire dosage) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
got diarrhea; still having discomfort; This case was reported by a consumer via interactive digital media and described the occurrence of diarrhea in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th November 2020, the patient received the 2nd dose of Shingrix. On 13th November 2020, 1 days after receiving Shingrix, the patient experienced diarrhea. In November 2020, the patient experienced discomfort. On an unknown date, the outcome of the diarrhea and discomfort were not recovered/not resolved.   It was unknown if the reporter considered the diarrhea and discomfort to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had diarrhea and discomfort. The reporter asked it common for it to last this long.
This report might have been reported by doctor as requested by patient. Patient received a yellow fever vaccine VF-Vax-uf081AA on Oct. 9, 2007 and TYPHIM VI.5 dose on the same day. Within 24 hours, patient had raised inflamed welts on neck with fever and nausea. Patient contacted nurse, to report allergic reaction. Nurse reported that the usual reaction was a sore arm. Patient who was unable to drive to ER room called doctor. Doctor requested patient to come to office to be examined. When patient's husband returned home from a business trip two days later, patient was seen. Red welts were still visible. Patient never recovered fully from negative effects of the adverse effects of the vaccine. Memory and cognitive functions deteriorated and were confirmed at Hospital the following year. Two years after the vaccines, patient is still disabled. Patient told nurse she had Lyme disease before the vaccines. 10/21/2009 record from clinic that 24 hrs post vaccination, patient had sx of welts, fever and nausea. Stated patient suffered decreased  memory and cognitive functions resulting in permanent disability.
pt recv vax 23MAY95 & 26MAY95 pt mom noted that had a fever of 104; 31MAY95 devel a rash that was dx as roseola; exp was not a vax rxn; 01JUN95 pt recovered;
chills; felt extremely unwell; This is a spontaneous report from a non-contactable consumer (patient). A female patient of unspecified age received second dose of BNT162B2, via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 for COVID-19 immunization on an unspecified date. The patient received her 2nd Pfizer COVID-19 vaccine on Wednesday (unknown date). She experienced chills and felt extremely unwell on Thursday and Friday (unknown date). She recovered completely by yesterday morning (05Feb2021). The patient recovered from both events on 05Feb2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recv vax 8MAR96 & on 26FEB97 pt devel a chickenpox like rash consisting of bumps w/fluid;devel approx 10 lesions on back;fever & itchiness;pt was doing OK @ the time of the report;
On 10-30-07 mother stated after 7-31-07 immunizations , child would cry (high pitched) for 1 hr at a time Called Dr - No further pertussis
on 8apr99 pt recv 5th dose of vax & exp temp of 101.5, inject site redness, & arm swollen fr shoulder to elbow. treated w/cold packs & tylenol
Vial was initially stored in the refrigerator on 28-MAY-2022 and dose was administered in 29-MAY-2022; no adverse event; 4 adult patients received Monovalent vaccine 9 day after MFG expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 adult patients received Monovalent vaccine 9 day after MFG expiration date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 28-MAY-2022 and dose was administered in 29-MAY-2022) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 033K21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 29-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 adult patients received Monovalent vaccine 9 day after MFG expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 28-MAY-2022 and dose was administered in 29-MAY-2022) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 adult patients received Monovalent vaccine 9 day after MFG expiration date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 28-MAY-2022 and dose was administered in 29-MAY-2022) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (4 adult patients received Monovalent vaccine 9 day after MFG expiration date) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 28-MAY-2022 and dose was administered in 29-MAY-2022).    No concomitant medications were reported. 8 adult patients received monovalent vaccine Beyond manufacture Expiration Date. It was reported that expiry date of vaccine had not been extended. It was unbroken cartons. Vial size was reported as 5.5 mL. Vial was initially stored in the refrigerator 20-MAY-2022 and 28-MAY-2022. 4 adult patients on 21-MAY-2022 and 4 more adult patients on 29-MAY-2022. Vial did not undergo any temperature excursions. No treatment information was provided. This case contains information for the 6th of 8 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-679408, US-MODERNATX, INC.-MOD-2022-679142, US-MODERNATX, INC.-MOD-2022-679409, US-MODERNATX, INC.-MOD-2022-679410, US-MODERNATX, INC.-MOD-2022-679412, US-MODERNATX, INC.-MOD-2022-679414, US-MODERNATX, INC.-MOD-2022-679415 .; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-679408:same reporter US-MODERNATX, INC.-MOD-2022-679142:same reporter US-MODERNATX, INC.-MOD-2022-679409:same reporter US-MODERNATX, INC.-MOD-2022-679410:same reporter US-MODERNATX, INC.-MOD-2022-679412:same reporter US-MODERNATX, INC.-MOD-2022-679414:same reporter US-MODERNATX, INC.-MOD-2022-679415:same reporter
Extreme Fatigue Dizziness Fever, body aches Tingling, and numbness to the injected arm (right) Severe headache
Pt exp "swelling & a reddish rash" believes to be on the arm where pt recvd Engerix-B; Reporter stated pt also recvd a TB test "around the same time as the vax;
intermittent numbness to Left hand/wrist  Narrative: Pt in vaccine clinic observation area with complaints of intermittent numbness to Lt hand/wrist. No treatment given and symptoms resolved after 20 minutes.
This spontaneous report as received from a pharmacist refers to an unknown number of patient of unknown age. The patients were vaccinated with doses of PNUEMOVAX23 (lot# not reported) stored as high as 9 C several times a day for an unknown period of time. No adverse effect was reported. It was unknown if the patient sought medical attention. Follow up information has been received from the pharmacist stating that all patient information was recorded in the Immunization Registry. At the time of reporting, the pharmacist did not have access to the information that was listed in the Immunization Registry. The pharmacist stated that she would speak to her supervisor to see if patient identifiers could be supplied. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a pharmacist, via company representative and refers to a 72 year old female patient. No information regarding the patient's medical history, concurrent conditions and concomitant therapies was provided. On 13-NOV-2017, the patient was vaccinated with PNEUMOVAX 23 (strength, dose, route of administration, lot # and expiration date were not provided) for prophylaxis. Other suspect therapies included unspecified influenza virus vaccine (strength, dose, route of administration, lot # and expiration date were not provided), administered in the same arm as the PNEUMOVAX 23. On 13-NOV-2017, the patient's arm swelled horribly. The swelling lasted for three days. The patient did not seek medical attention. No treatment was given for the adverse event. The outcome of arm swelling was reported as unknown. The relatedness between PNEUMOVAX 23 and arm swelling was not reported. No product quality complaint was involved.
Narrative: Itchiness after getting the Covid vaccine at about 3 PM today without any associated hives, swelling, chest pain or shortness of breath. Patient sent to  ED from vaccine clinic. Patient had previous allergic reaction to typhoid and  influenza vaccine, Prior to this she has been well. After administration of  medications, patient felt significantly better and discharged from ED.
On the next day had redness and swelling around the injection site.  Painful to move the arm, but that subsided.   Had a pretty big bump on her arm at the injection site.  Still like that on Friday, 2 days later.  Went to her internist and he put her on Zyrtec and Cortisone cream.  She did that until it had nearly subsided which took about a week.  She stopped this treatment, and then 24 hours after that it all returned worse.  She took a picture and sent it to her internist which she saw yesterday, 2/4/21.  He put her on an antibiotic and felt that it could be an infection at the injection site.  He put her on Doxycycline.  He told her to get the 2nd vaccine despite the side effects.   States that she never felt any headache, nausea or internal side effects, just the symptoms at the injection site.  He told her to continue with Zyrtec and Cortisone until the symptoms are gone.
joint ligament pain on my shoulder at the injection shot site; almost it feels kind of dislocated; rest on the injection arm too; then on my elbow; along with the fever of 100.2 Fahrenheit.; like ligament pain on my shoulder; at the injection site; my right breast almost; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 24 year-old female patient received bnt162b2 (BNT162B2), administration date 21Dec2021 (Lot number: FE3594) at the age of 24 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE-1, LOT number of ER8733 , expiration date as 31Jul2021), administration date: 30Mar2021, for Covid-19 immunization; Bnt162b2 (DOSE-2, LOT number of EW0162 , expiration date as 31Jul2021), administration date: 20Apr2021, for Covid-19 immunization. The following information was reported: INJECTION SITE JOINT PAIN (non-serious) with onset 22Dec2021, outcome "not recovered", described as "joint ligament pain on my shoulder at the injection shot site"; JOINT DISLOCATION (non-serious) with onset 22Dec2021, outcome "not recovered", described as "almost it feels kind of dislocated"; PAIN IN EXTREMITY (non-serious) with onset 22Dec2021, outcome "not recovered", described as "rest on the injection arm too"; ARTHRALGIA (non-serious) with onset 22Dec2021, outcome "not recovered", described as "then on my elbow"; PYREXIA (non-serious) with onset 22Dec2021, outcome "not recovered", described as "along with the fever of 100.2 Fahrenheit."; LIGAMENT PAIN (non-serious) with onset 22Dec2021, outcome "not recovered", described as "like ligament pain on my shoulder"; INJECTION SITE PAIN (non-serious) with onset 22Dec2021, outcome "not recovered", described as "at the injection site"; BREAST PAIN (non-serious) with onset 22Dec2021, outcome "not recovered", described as "my right breast almost". Relevant laboratory tests and procedures are available in the appropriate section. Consumer stated, she wanted to report a side effect and got from my Pfizer booster shot that, the patient received yesterday. It was almost like a joint ligament pain on her shoulder at the injection shot site and then on her elbow and rest on the injection arm too, almost it feels kind of dislocated.  No follow-up attempts are possible. No further information is expected.
Very short of breath, wheezing, scratchy throat, scratch body, swollen eyes, swollen lips, bloodshot eyes, body aches, head ache, severe congestion, very dizzy/
persistent uncontrollable crying for 6/12/ hrs p/vax; 1st DTP inj 13SEP93 w/no rxn;
Systemic: Dizziness / Lightheadness-Mild, Systemic: Hypotension-Mild, Additional Details: Patient states 10 minutes after the shot she was feeling lightheaded and dizzy. Patient was instructed to remain seated and she never lost consciousness. BP was taken at that time and was 92/79 which is slightly low for patient. Patient states she is needle phobic and did get a similar reaction during first shot. Patient was observed for another 15-20 minutes while seating and given water to drink. She states she felt better and her BP was retaken at that time and read 130/80 which is normal.